Skip to Main Content

Advertisement

Skip Nav Destination

Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian Carcinoma

Cancer Res (2022) 82 (2): 307–319.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Xiaoyu Fu
  • Ping Li
  • Qi Zhou
  • Ruyuan He
  • Guannan Wang
  • Shiya Zhu
  • Amir Bagheri
  • Gary Kupfer
  • Huadong Pei
  • Juanjuan Li
Genes & Diseases (2024) 11 (1): 306.
  • Jiyeon Han
  • Min Ji Kang
  • Sanghyuk Lee
Computers in Biology and Medicine (2024) 174: 108436.
  • Shuangshuang Zeng
  • Zhijie Xu
  • Yuanhong Liu
  • Shangjun Zhou
  • Yuanliang Yan
Chemico-Biological Interactions (2024) 393: 110958.
  • Janice M. Santiago-O’Farrill
  • Alicia Blessing Bollu
  • Hailing Yang
  • Vivian Orellana
  • Marc Pina
  • Xudong Zhang
  • Jinsong Liu
  • Robert C. Bast
  • Zhen Lu
Molecular Cancer Research (2024) 22 (9): 840.
  • Wu Lixing
  • Cao Lin
  • Yang Lijun
  • Xu Xiaojin
  • Shen Zhuyang
  • Zhao Juan
  • Liu Linsheng
  • Huang Dan
Metabolic Syndrome and Related Disorders (2024) 22 (10): 726.
  • Yaqi Zhang
  • Yinu Wang
  • Guangyuan Zhao
  • Sandra Orsulic
  • Daniela Matei
Pharmacology & Therapeutics (2023) 245: 108413.
  • Curtis A. Clark
  • Eddy S. Yang
Journal of Immunotherapy and Precision Oncology (2023) 6 (1): 31.
  • Sangsang Tang
  • Yuanming Shen
  • Xinyi Wei
  • Zhangjin Shen
  • Weiguo Lu
  • Junfen Xu
Cell Death & Disease (2022) 13 (9)
  • Xiang Chen
  • Peipei Yang
  • Yue Qiao
  • Fei Ye
  • Zhipeng Wang
  • Mengting Xu
  • Xiaowang Han
  • Li Song
  • Yuehong Wu
  • Wen-Bin Ou
Scientific Reports (2022) 12 (1)
  • Nannan Wang
  • Yan Yang
  • Dongdong Jin
  • Zhenan Zhang
  • Ke Shen
  • Jing Yang
  • Huanhuan Chen
  • Xinyue Zhao
  • Li Yang
  • Huaiwu Lu
Frontiers in Pharmacology (2022) 13
  • Aikaterini Skorda
  • Marie Lund Bay
  • Sampsa Hautaniemi
  • Alexandra Lahtinen
  • Tuula Kallunki
Cancers (2022) 14 (24): 6257.
Close Modal

or Create an Account

Close Modal
Close Modal